The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Cambridge's AVROBIO Lands $60M to Push Fabry, Rest of Pipeline Into the Clinic January 31, 2018 <b>Nemaura Medical Inc.</b> Announces Uplist To OTCQB July 9, 2017 The 5 Key Drugs That Need to Keep Performing to Keep Johnson & Johnson on Top October 22, 2017